# Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis

> **NCT02183038** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 390 (actual)

## Conditions studied

- Pharyngitis

## Interventions

- **DRUG:** Meloxicam low
- **DRUG:** Meloxicam high
- **DRUG:** Naproxen sodium
- **DRUG:** Meloxicam placebo low
- **DRUG:** Meloxicam placebo high
- **DRUG:** Naproxen sodium placebo

## Key facts

- **NCT ID:** NCT02183038
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-07
- **Primary completion:** 1999-02
- **Final completion:** —
- **Target enrollment:** 390 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02183038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02183038, "Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02183038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*